期刊文献+

安徽省2006~2011年麻风病复发患者调查分析 被引量:4

Analysis of recucring-case of lepriasis from 2006 to 2011 in Anhui province
原文传递
导出
摘要 目的了解麻风病复发情况和特点,为防治工作提供依据。方法对2006-2011年安徽省麻风复发病例进行流行病学调查。结果 2006~2011年全省报告麻风复发病例16例,男性14例,女性2例。复发年龄为41~71岁,平均50岁。其中氨苯砜(DDS)单疗治愈复发者9例(PB4例,MB 5例),占56.25%;联合化疗(MDT)治愈复发者7例(PB 4例,MB 3例),占43.75%。治愈至复发的时间为9~402个月,平均200个月。DDS复发时间较晚为124~370个月,MDT为9~184个月。发现方式主要以自报为主,其次是门诊、随访发现。结论麻风病愈后长时间内都有复发的危险,要加强麻风愈后的随访工作。在麻风低流行状态下控制复发和及时发现复发病例是麻风防治工作的重要内容。 Objective To study clinical characteristics and the trends of leprosy relapse cases,and provide evidence for leprosy control.Method Descriptive analysis of data from the national leprosy surveillance system was carried out from 2006 to 2011.Result There were a total of 16 leprosy relapse cases reported during 2006-2011.Of them,there were 14 males and 2 females.Their ages ranged from 41-71 years,and the average age was 50 years.9(4 PB,5 MB) cases were relapsed after DDS monotherapy and 7(4 PB,3 MB) were relapsed after MDT.The proportions of DDS and MDT were 56.25% and 43.75%,respectively.The latent period ranged from 9-402 months with average latent period of 200 months.The latent period of DDS was 124-370 months and MDT was 9-184 months.Most of the patients were found by themselves.Conclusion There is a risk of relapse of leprosy during a long time after being cured,we should strengthen the follow-up work of cured patients.Controlling and finding relapse patients is important work of leprosy control on low prevalence stage.
作者 王强
出处 《安徽预防医学杂志》 2013年第3期183-184,187,共3页 Anhui Journal of Preventive Medicine
关键词 联合化疗 麻风病 复发特征 MDT Lepriasis Recurrence
  • 相关文献

参考文献5

二级参考文献21

  • 1沈建平,李文忠,严良斌,叶干运,骆钧,陈文华,邵玉生,贺挺书,莫焕春,陶朗,吕绍泉,顾刚,吕丁文,皋官蔚.多菌型麻风联合化疗和监测的10年观察结果[J].中华皮肤科杂志,1996,29(4):255-257. 被引量:9
  • 2徐春茂,邱耀文,王斌,伏永鹏,白莉,穆洮俊,张宏茂,李志诚,王德英,冯福勤.甘肃省麻风病人血缘性与非血缘性亲属家庭发病的对比研究[J].中国麻风皮肤病杂志,2005,21(11):882-884. 被引量:8
  • 3赖祖杰,段森,张桂芳,李郁文,常玉萍.667例多菌型麻风MDT后监测5年[J].中国麻风杂志,1996,12(2):104-105. 被引量:8
  • 4Kroger A, Pannikar V, Htoon MT, et al. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results. Trop Med Int Health, 2008, 13(5): 594-602.
  • 5Becx-Bleumink M. Duration of muhidrug therapy in paueibaeillary patients; experiences in the leprosy control program of the ALL Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis, 1992, 60: 436-444.
  • 6Kar PK, Jha PK, Panayach JS, et al. A clinico-pathological study of multidrug regimen in paucibacillary leprosy. Indian J Lepr, 1988, 60(2): 235-241.
  • 7Katoch K, Natarajan M, Katoch VM, et al. Chemotherapy trial in paucibacillary leprosy using clofazimine. Indian J Lepr, 1999, 71 (3): 311-324.
  • 8MF Ballagon, RV Cellona and PR Saunderson, Type 2 (ENL) reactions observed in MB patients treated with one year and with two year WHO-MDT. 17th International Leprosy Congress, Abstract, O-22, p72.
  • 9WHO.Enhanced Global Strategy for Further Reducing the Disease Burden due to Leprosy(Plan Period:2011-2015).WHO Regional Office for South-East Asia.New Delhi,2009.
  • 10WHO.Global leprosy situation,2009.Weekly Epidemiol Rec,2009,84(33):333-340.

共引文献68

同被引文献27

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部